245 related articles for article (PubMed ID: 9831326)
21. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils.
Ikemura T; Manabe H; Sasaki Y; Ishii H; Onuma K; Miki I; Kase H; Sato S; Kitamura S; Ohmori K
Int Arch Allergy Immunol; 1996 May; 110(1):57-63. PubMed ID: 8645979
[TBL] [Abstract][Full Text] [Related]
22. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptides modulate human eosinophil chemotaxis.
Numao T; Agrawal DK
J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
[TBL] [Abstract][Full Text] [Related]
26. IgA-induced eosinophil degranulation.
Abu-Ghazaleh RI; Fujisawa T; Mestecky J; Kyle RA; Gleich GJ
J Immunol; 1989 Apr; 142(7):2393-400. PubMed ID: 2926137
[TBL] [Abstract][Full Text] [Related]
27. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
Ezeamuzie CI; al-Hage M; Nwankwoala RN
Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
[TBL] [Abstract][Full Text] [Related]
28. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
Sehmi R; Rossi AG; Kay AB; Cromwell O
Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
[TBL] [Abstract][Full Text] [Related]
29. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.
Coëffier E; Joseph D; Vargaftig BB
Br J Pharmacol; 1994 Nov; 113(3):749-56. PubMed ID: 7858864
[TBL] [Abstract][Full Text] [Related]
30. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
Ng CF; Sun FF; Taylor BM; Wolin MS; Wong PY
J Immunol; 1991 Nov; 147(9):3096-103. PubMed ID: 1655904
[TBL] [Abstract][Full Text] [Related]
31. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
32. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
Horie S; Kita H
J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
[TBL] [Abstract][Full Text] [Related]
34. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
Suwaki T; Agrawal DK; Townley RG
Int Immunopharmacol; 2001 Nov; 1(12):2163-71. PubMed ID: 11710545
[TBL] [Abstract][Full Text] [Related]
35. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases.
Woerly G; Loiseau S; Loyens M; Schoch C; Capron M
Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326
[TBL] [Abstract][Full Text] [Related]
37. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
[TBL] [Abstract][Full Text] [Related]
38. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis].
Numao T; Fukuda T; Akutsu I; Makino S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S
Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299
[TBL] [Abstract][Full Text] [Related]
40. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
Turner NC; Wood LJ; Foster M; Gueremy T
Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
